Bincike ya nuna cewa ana iya amfani da PixCell's HemoScreen ™ don saka idanu samfuran jini da haɓaka tsarin jiyya na marasa lafiya da cututtukan jini.
ILIT, York, Isra'ila, Oktoba 13, 2020 / PRNewswire/ - PixCell Medical, mai ƙirƙira na saurin maganin cututtukan gado, a yau ya sanar da sakamakon sabon binciken da aka buga a cikin Jarida ta Duniya na Laboratory Hematology A sakamakon haka, binciken ya nuna cewa Kamfanin HemoScreen ™ mai nazarin jini na gefen gado ya dace da kimantawa da sarrafa masu cutar kansar jini da ke jurewa maganin chemotherapy.
Masu bincike daga Asibitin Arewacin New Zealand, Jami'ar Copenhagen, Bispebjerg da Asibitocin Frederiksberg a Copenhagen, da Jami'ar Kudancin Denmark sun kwatanta HemoScreen ™ da Sysmex XN-9000 a cikin samfuran jijiya na yau da kullun na 206 da 79 farin kwayar jini (WBC) gadon capillary. Samfurori , Cikakken neutrophil count (ANC), jan jini cell (RBC), platelet count (PLT) da haemoglobin (HGB).
"Masu ciwon daji da ke fama da ƙwayar cuta mai tsanani sau da yawa suna fama da mummunan ƙwayar kasusuwa saboda jiyya kuma suna buƙatar kulawa na yau da kullum na cikakken adadin jini (CBC)," in ji Dokta Avishay Bransky, Shugaba na PixCell Medical."Wannan binciken ya nuna cewa HemoScreen na iya samar da sakamako mai sauri da aminci don samfurori na gabaɗaya da samfuran cututtukan cututtuka.Yaduwar amfani da wannan na'urar na iya kawar da ziyarar asibiti marasa mahimmanci kuma yana rage lokacin shawarwarin da ya dace-ga waɗanda ke fama da rashin lafiya da gajiya.Ga marasa lafiya, wannan wasa ne mai sauya wasa."
Bayanan sun nuna cewa HemoScreen yana amfani da 40 μl na venous ko jini na capillary da ƙananan matakan WBC, ANC, RBC, PLT da HGB don samar da sakamakon gwaji mai sauri da aminci na asibiti don jagorantar ƙarin jini da magani bayan chemotherapy.Har ila yau, ƙungiyar binciken ta gano cewa HemoScreen ya isa ya kula da lakabin samfurori na pathological da ƙananan kwayoyin halitta (ciki har da kwayoyin jajayen jini, granulocytes da ba su da girma, da kuma sel na farko), kuma yana rage girman lokacin juyawa na sakamakon gwaji.
HemoScreen™, wanda PixCell Medical ya haɓaka, shine kawai mai nazarin ilimin jini da FDA ta amince da shi, wanda aka ƙera don kulawa (POC), haɗa cytometry kwarara da hoto na dijital akan dandamali ɗaya.Mai šaukuwa šaukuwa m hematology analyzer iya kammala cikakken jini kirga (CBC) gwajin a cikin minti 6, kuma yana amfani da wani juwa kit pre-cike da duk masu zama dole reagents don azumi, daidai kuma sauki gwaje-gwajen dakin gwaje-gwaje.
Binciken ya kammala cewa HemoScreen ya dace sosai ga ƙananan asibitocin waje kuma yana iya dacewa da amfani da gida.
PixCell Medical yana ba da mafita ta farko ta ainihin šaukuwa na gwajin jini nan take.Yin amfani da fasahar mai da hankali na viscoelastic na kamfanin da hangen nesa na injin wucin gadi, PixCell's FDA-amince da dandamalin bincike na HemoScreen na CE yana rage lokacin isar da sakamakon bincike daga ƴan kwanaki zuwa ƴan mintuna.Tare da digon jini kawai, PixCell na iya samar da ingantaccen karatu na daidaitattun ma'auni na ƙididdigar jini 20 a cikin mintuna shida, ceton marasa lafiya, likitocin da tsarin kiwon lafiya mai yawa lokaci da farashi.
Lokacin aikawa: Yuli-15-2021